Business Wire · ARWR · November 7, 2026

Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates

Get the app for more

Explore stock news, insights and company research.